Skip to Content

Isotechnika Selected to Present at International Transplantation Conference

EDMONTON, Alberta - September 24, 2008 (ISA:TSX): Isotechnika Inc. today announced Dr. Cantarovich, a principal investigator from the Company's recently completed Phase 2b kidney transplant trial (PROMISE), has been selected to make a poster presentation at the International Society of Nephrology Nexus Symposium on Transplantation and the Kidney to be held in Rome, Italy, September 25-28, 2008.

Dr. Cantarovich will make his poster presentation titled "Efficacy and Impact on Renal Function of Voclosporin (ISA247): The Phase 2 'PROMISE' Trial in De Novo Renal Transplant Recipients" on Friday, September 26th, 2008. Interested parties will be able to access the poster by visiting the "Presentations" folder in the "For Investors" section of the Company's corporate website at>


For more information:

Stephanie Gillis-Paulgaard

Director, Corporate Communications

Isotechnika Inc.


Fax:780-484-4105 <



Posted: September 2008

View comments